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Commonality despite exceptional diversity in the 
baseline human antibody repertoire
Bryan Briney1,2,3,4,5*, Anne Inderbitzin1,6, Collin Joyce1,2,3,4 & Dennis r. Burton1,2,4,5,7*
In principle, humans can produce an antibody response to any non-
self-antigen molecule in the appropriate context. This flexibility is 
achieved by the presence of a large repertoire of naive antibodies, the 
diversity of which is expanded by somatic hypermutation following 
antigen exposure1. The diversity of the naive antibody repertoire in 
humans is estimated to be at least 1012 unique antibodies2. Because 
the number of peripheral blood B cells in a healthy adult human is 
on the order of 5 × 109, the circulating B cell population samples 
only a small fraction of this diversity. Full-scale analyses of human 
antibody repertoires have been prohibitively difficult, primarily 
owing to their massive size. The amount of information encoded 
by all of the rearranged antibody and T cell receptor genes in one 
person—the ‘genome’ of the adaptive immune system—exceeds the 
size of the human genome by more than four orders of magnitude. 
Furthermore, because much of the B lymphocyte population is 
localized in organs or tissues that cannot be comprehensively 
sampled from living subjects, human repertoire studies have 
focused on circulating B cells3. Here we examine the circulating B 
cell populations of ten human subjects and present what is, to our 
knowledge, the largest single collection of adaptive immune receptor 
sequences described to date, comprising almost 3 billion antibody 
heavy-chain sequences. This dataset enables genetic study of the 
baseline human antibody repertoire at an unprecedented depth 
and granularity, which reveals largely unique repertoires for each 
individual studied, a subpopulation of universally shared antibody 
clonotypes, and an exceptional overall diversity of the antibody 
repertoire.
Eighteen sequencing libraries were generated for each of ten subjects 
(Extended Data Fig. 1). These libraries yielded 2.90 × 109 raw reads. 
After annotation4, which included duplicate removal using unique 
molecular identifiers5, we obtained 3.64 × 108 productive antibody 
sequences (Extended Data Table 1).
Amplification was reproducible, with similar gene usage between 
replicates (Fig. 1a, Extended Data Fig. 2). The frequencies of IgM-
encoding (0.62–0.94) and IgG-encoding (0.06–0.38) sequences were 
consistent with the expected frequency of circulating B cells that 
express these isotypes6 (Fig. 1b). Although V-gene, J-gene and CDRH3 
length distributions were similar between subjects (Fig. 1c, e, f), differ-
ences were large enough that individual repertoires could conceivably 
be distinguished using only these features. We reduced sequence sub-
samples to the frequency distributions of V-gene, J-gene and CDRH3 
length, and quantified similarity using the Morisita–Horn similarity 
index7,8. Subject repertoires were clearly distinguishable using as few 
as 104 sequences (Fig. 1d, Extended Data Fig. 4) and did not cluster 
by age, gender or ethnicity (Fig. 1g). The IgG+ repertoires were least 
similar, suggesting that the unique immunological histories of subjects 
are a substantial contributor to repertoire individuality (Fig. 1h). A 
one-versus-rest support-vector-machine classifier trained on V-gene, 
J-gene and CDRH3 length data from 5 of the 6 biological replicates 
from each subject accurately assigned the remaining replicate using 
test or training datasets of as few as 500 sequences from each replicate 
(Fig. 1i).
To estimate repertoire diversity and minimize the effects of sequenc-
ing and amplification error, we first considered clonotype diversity. An 
antibody clonotype is a collection of sequences using the same V and J 
genes, and encoding an identical CDRH3 amino acid sequence9. For 
each subject, all sequences from each biological replicate were collapsed 
into a set of unique clonotypes. Any clonotypes that were repeatedly 
observed after pooling de-duplicated biological replicates must be 
derived from different cells, which provides a straightforward means 
of quantifying multiple occurrence. For clarity, clonotypes or sequences 
present in multiple biological replicates from a single subject will be 
referred to as ‘repeatedly observed’, whereas clonotypes or sequences 
found in multiple subjects will be referred to as ‘shared’.
Rarefaction curves indicated a low frequency of repeatedly observed 
clonotypes, which is supported by capture–recapture sampling 
(3.9–11.7% recapture; Fig. 2a, Extended Data Fig. 6). To estimate 
repertoire diversity, we selected two estimators: Chao 2 and Recon. 
Chao 2 is a non-parametric estimator that uses repeat occurrence 
data from multiple samples to estimate species richness10. Recon uses 
maximum likelihood to estimate species richness, assuming only that 
the overall size of the repertoire is large (relative to sampling depth) 
and well-mixed11. These estimates represent the total diversity that the 
humoral immune system is capable of generating. Accordingly, these 
estimates may greatly exceed the actual number of B cells present in 
a single individual at any one time. The estimators produced similar 
estimates of clonotype diversity for each subject, with identical rank 
order (Fig. 2b). Recon consistently estimated about twofold greater 
repertoire diversity (2 × 107–1 × 109) than Chao 2 (1 × 107–5 × 108), 
consistent with reports that Chao 2 underestimates richness for samples 
with a non-negligible frequency of rare species12,13. Pooling unique 
clonotypes from multiple subjects enabled us to estimate cohort-wide 
diversity (Fig. 2c). Chao 2 (5 × 109) and Recon (5 × 109) produced 
nearly identical estimates for the complete ten-subject pool. Estimates 
of cohort-wide clonotype diversity exceed individual subject estimates 
by less than two orders of magnitude, which suggests a relatively high 
frequency of shared clonotypes. We next sought to estimate the 
sequence diversity for each individual, again using both the Chao 2 
and Recon estimators (Fig. 2d). As expected, the estimates for 
sequences were substantially higher than for clonotypes, with Chao 2 
(2 × 108–2 × 109) and Recon (1 × 108–2 × 109) producing comparable 
estimates for each subject. Unlike the cohort-wide clonotype esti-
mates, Recon estimated much lower cohort-wide sequence diversity 
(1 × 1010) than Chao 2 (1 × 1011; Fig. 2e). The light-chain repertoire 
is estimated to be approximately four orders of magnitude less diverse 
than the heavy-chain repertoire (Extended Data Fig. 7) and pairing 
of heavy and light chains is approximately random14, which produces 
a total paired-sequence diversity estimate of 1016 to 1018. The most 
commonly cited estimate of antibody repertoire diversity—1012 unique 
sequences2—considers only the unmutated naive repertoire. As such, 
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our sequence diversity estimates, which include both the naive and 
memory sequences, are not directly comparable to this previous esti-
mate. Clonotype diversity estimates—which incorporate only V- and 
J-gene assignments, and the CDRH3 amino acid sequence—minimize 
the influence of somatic hypermutation, and are more suitable for 
comparison with previous estimates of naive repertoire diversity. The 
cohort-wide paired clonotype diversity using either estimator, under 
the same assumptions regarding light-chain diversity and random 
pairing, is estimated at 3 × 1015—over three orders of magnitude 
greater than previously estimated for the naive repertoire.
Although it is known that convergent antibodies may arise from 
different individuals in response to immunological exposure, and 
a low frequency of CDRH3 sharing has previously been observed 
in healthy adult repertoires9,15, the overall prevalence of repertoire 
sharing is unknown. For each combination of two or more subjects, 
we computed the frequency of shared clonotypes (Fig. 3a). Pairs of 
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Fig. 1 | Uniqueness of the repertoires of individual subjects.  
a, Frequency comparison of V and J combinations in biological replicates 
from subject 326650. V and J combinations are coloured according to 
the V gene used. b, Sequence frequency by antibody isotype. Subjects 
are coloured as in c. Each point represents a single biological replicate. 
Mean of all samples is indicated for each isotype. c, CDRH3 length 
distribution for each subject. CDRH3 lengths were determined using 
the Immunogenetics (IMGT) numbering scheme. AA, amino acids. 
d, Morisita–Horn similarity of pairwise comparisons between subject 
316188 and each of the other subjects. Lines indicate mean similarity 
of 20 bootstrap samplings, and shaded areas indicate 95% confidence 
intervals. Data from subject 316188 are representative; plots for all other 
subjects can be found in Extended Data Fig. 4. e, f, V gene (e) and J gene 
(f) use by subject. Increased colour intensity indicates higher frequency. 
Subjects are coloured as in c. g, Clustered distance matrix of subjects, 
using pairwise Morisita–Horn similarity of V-gene, J-gene and CDRH3 
length as the distance measure. Distance matrix was computed using 
single-linkage clustering (Euclidean distance metric). Subject colours 
are as in c. A dendrogram representation of the distance matrix is also 
shown on the left side of the distance matrix. h, Comparison of intra- and 
inter-subject similarity in V-gene, J-gene and CDRH3 length, using all 
sequences, IgM sequences with fewer than two nucleotide mutations, IgM 
sequences with two or more mutations, or IgG sequences. Points represent 
individual intra- or inter-subject comparisons. Box plots show the median 
line and span the 25th–75th percentile, with whiskers indicating the 95% 
confidence interval. i, Mean receiver operating characteristic (ROC) area 
under the curve (AUC) for a one-versus-rest support-vector-machine 
classifier. The ROC AUC does not drop below 1.0 for any subject when the 
test or training datasets include ≥ 500 sequences each; this 500-sequence 
threshold is indicated with a dashed vertical line.
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subjects shared—on average—0.95% of their respective clonotypes, and 
0.022% of clonotypes were shared by all ten subjects. We next used two 
approaches to quantify the expected frequency of clonotype sharing by 
chance. Hypergeometric distributions, based on cohort-wide clonotype 
diversity (Chao 2) and the number of unique clonotypes for each sub-
ject, indicated a low likelihood that the observed sharing was due to 
chance (8.8 × 10−6, Bonferroni-corrected P = 0.05 is 1.1 × 10−3). We 
also generated synthetic antibody sequences using IGoR16 to determine 
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Fig. 2 | Clonotype and sequence diversity amongst the 10 subjects.  
a, Clonotype rarefaction curves for each subject. Lines represent the mean 
of 10 independent samplings, with the exception of the 1.0 fraction (which 
was sampled once). The dashed line represents a perfectly diverse sample. 
Inset is a close-up of the ends of the rarefaction curves. b, Estimates of 
total repertoire diversity per clonotype were computed for increasingly 
large fractions of the clonotype repertoire of each subject. Each line 
represents the mean of 10 random subsamplings without replacement 
(except for the 1.0 fraction). Chao 2 (C) estimates are shown in solid lines, 
Recon (R) estimates are shown in dashed lines. Subject colours are as in 
a. Maximum diversity (1.0 fraction of each subject) for each estimator is 
shown in the right panel. c, Overall cross-subject clonotype diversity of 
each possible combination of one or more subjects. The Chao 2 estimate 
is a solid line and the Recon estimate is a dashed line. Shaded regions 
indicate 95% confidence intervals. The confidence intervals in c are 
for different groupings of subjects, not for the estimators themselves. 
d, Estimates of total sequence repertoire diversity were computed for 
increasingly large fractions of the sequence repertoire of each subject. 
Each line represents the mean of 10 random subsamplings without 
replacement (except for the 1.0 fraction, for which only a single calculation 
was made). Chao 2 estimates are shown in solid lines, Recon estimates 
are shown in dashed lines. Subject colours are as in a. Maximum diversity 
(1.0 fraction of each subject repertoire) for each estimator is shown in the 
right panel. e, Overall cross-subject nucleotide sequence diversity of each 
possible combination of one or more subjects. The Chao 2 estimate is a 
solid line and the Recon estimate is a dashed line. Shaded regions indicate 
95% confidence intervals. Confidence intervals are as in c.
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the expected frequency of clonotype sharing due to coincident V(D)J 
recombination. Synthetic sequence sets were generated using three 
different recombination models: (1) IGoR’s default model, inferred 
from unproductive antibody rearrangements and thus focused only 
on parameters related to V(D)J recombination; (2) subject-specific 
recombination models inferred from unmutated sequences from each 
subject; and (3) a combined-subject recombination model inferred 
from a pool of unmutated sequences drawn from all subjects. For each 
model, 10 batches of 108 sequences were generated, for a total of 3 bil-
lion synthetic sequences. In the sequence sets generated with IGoR’s 
default model, clonotype sharing was sevenfold lower than in human 
repertoires (0.0032%; Fig. 3b), which indicates that coincident V(D)J 
recombination alone is not sufficient to explain the observed sharing. 
The subject-derived synthetic sequence sets showed much more shar-
ing (0.1% and 0.16%, respectively; Fig. 3b, Extended Data Fig. 8). In 
addition to containing information about V(D)J recombination, the 
subject-derived models also implicitly encode information about the 
selection processes involved in B cell development. The increased 
frequency of clonotype sharing in subject-derived synthetic datasets 
indicates that the sieving effect of B cell development produces naive 
repertoires that are more similar than recombination alone would 
be expected to produce. Combined with our observation that naive- 
enriched repertoires are more similar to each other than are class-
switched repertoires (Fig. 1h), a model emerges in which individual 
repertoires are very dissimilar after V(D)J recombination, are homo-
genized during B cell development and become increasingly individ-
ualized following differential responses to immunological exposure.
The length distributions of CDRH3s in unique and repeatedly 
observed clonotypes were similar, whereas short CDRH3s were much 
more common in shared clonotypes (Fig. 3c, d). The skew towards 
short CDRH3s in the shared population is probably due to the 
increased probability of similar recombination events among shorter 
CDRH3s. By contrast, repeatedly observed clonotypes are more often 
the result of clonal expansion, as evidenced by their increased mutation 
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Fig. 3 | Shared clonotypes and sequences amongst the 10 subjects. 
a, Venn diagram of shared clonotype frequency. b, Shared clonotype 
frequency between subject groups. Points represent different group 
combinations. Observed sequences (black), synthetic sequences generated 
with IGoR’s default model (red) and sequences generated with subject-
specific models (blue) are shown. c, Distribution of CDRH3 lengths for 
clonotypes found in one biological replicate (top) or all six biological 
replicates (bottom). CDRH3 length is defined using IMGT numbering. 
The colour key legend is split to maintain legibility; data for all subjects 
are present in both plots. d, Distribution of CDRH3 length for unshared 
clonotypes (top) or clonotypes shared by the majority of subjects (bottom). 
Observed sequences (black), default model (red) and subject-specific 
model (blue) synthetic sequences are shown. e, Per position Shannon 
entropy of the CDRH3 head regions of unshared (solid) or majority-
shared (dashed) clonotypes. Points indicate the mean, whiskers indicate 
the 95% confidence interval, and lines represent the linear best fit.  
f, g, Sequence logos of the CDRH3s encoded by observed unshared 
clonotypes, observed majority-shared clonotypes and synthetic majority-
shared clonotypes of length 8 (f) or 13 (g). Head-region amino acid 
colouring: polar amino acids (GSTYCQN) are green; basic amino acids 
(KRH) are blue; acidic amino acids (DE) are red; and hydrophobic amino 
acids (AVLIPWFM) are black. All torso residues are grey. h, Relative 
abundance of amino acid properties in the CDRH3s of majority-shared 
clonotypes. Abundances are normalized to the frequency in unshared 
clonotypes. i, Nucleotide mutations for singly observed or repeatedly 
observed clonotypes. Coloured lines indicate the mean for each subject; 
dashed black line indicates the mean of all subjects. j, Nucleotide 
mutations for shared or unshared clonotypes. Coloured lines indicate the 
mean for each subject; dashed black line indicates the mean of all subjects. 
k, Mutation frequency of nucleotide sequences shared by two or more 
subjects. Points indicate mean mutation frequency. The number of unique 
nucleotide sequences in each shared group is shown.
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frequency (Fig. 3i). Shared nucleotide sequences showed a strong 
inverse relationship between mutation frequency and the number of 
shared subjects (Fig. 3k); almost all sequences shared by four or more 
subjects were unmutated. Thus, although coincident recombination 
infrequently produces identical antibody sequences, the likelihood of 
coincident recombination being linked to an identical set of somatic 
mutations is exceptionally low.
Antibody CDRH3s can be divided into two primary regions: the 
framework-proximal ‘torso’ and the more-variable ‘head’17,18. When 
comparing size-matched samples of shared and unshared clonotypes, 
we noted less diversity in the head regions of shared clonotypes. 
Furthermore, head-region diversity in shared clonotypes was inversely 
related to length of CDRH3, which is a relationship that is not seen in 
unshared clonotypes or synthetic repertoires (Fig. 3e). This inverse 
relationship—along with the skewed distribution of CDRH3 lengths 
in shared clonotypes (Fig. 3d)—indicates that two distinct processes 
shape the shared clonotype population. The shortest shared CDRH3s 
encode head-region diversity, similar to unshared CDRH3s and syn-
thetic CDRH3s of the same length (Fig. 3f). Thus, short CDRH3s 
are probably shared primarily owing to their lower CDRH3 diversity 
and concomitantly higher likelihood of independent generation by 
coincident recombination. By contrast, longer shared CDRH3s are 
less diverse than unshared or shared synthetic populations (Fig. 3g), 
and more commonly encode head regions that are enriched in polar, 
uncharged residues and lack hydrophobic residues (Fig. 3h). This 
implies the existence of a mechanism by which these shared clono-
types are selected or enriched after recombination, on the basis of the 
biochemical properties of their CDRH3 regions.
In summary, sequencing the circulating B cell population of ten 
individuals at unprecedented depth has revealed repertoires that are 
highly individualized and extremely diverse. We estimate cohort-wide 
repertoire diversity of approximately 5 × 109 unique heavy-chain 
clonotypes, and as many as 1 × 1011 unique heavy-chain sequences. 
This indicates that the paired antibody diversity available to the 
circulating repertoire is very large, perhaps in the region of 1016–1018 
unique antibody sequences. Despite this enormous diversity, clono-
types are shared more frequently than would be expected from coin-
cident V(D)J recombination. Furthermore, we found that clonotype 
sharing is probably driven primarily by selection processes related 
to early B cell development rather than by convergent responses 
to common antigens. The possible clinical and diagnostic applica-
tions of sequencing the adaptive-immune repertoire are myriad— 
however, much work remains to be done before these applications can 
be implemented. The results described here are confined to circulating 
B cells, which represent a minority of the total B cell population. The 
repertories of circulating and tissue-resident B cells are known to dif-
fer19, and these differences may influence overall repertoire diversity 
and sharing. Furthermore, we have studied only ten individuals from 
a limited age range (18–30 years) and geographical region at a single 
time point. Much larger cohorts—representing diverse ethnicities, 
geographies and ages—will be required to capture the true population- 
wide repertoire diversity. Nevertheless, large-scale sequencing of 
the human adaptive-immune repertoire holds immense potential. 
Our use of high-level antibody-feature frequencies to differentiate 
repertoires raises the possibility of identifying and classifying 
discrete repertoire perturbations associated with autoimmune disease 
and chronic infection. Furthermore, because the repertoire of adaptive- 
immune receptors encodes a comprehensive record of an individ-
ual’s immunological encounters, leveraging large-scale sequencing 
of adaptive-immune receptors represents an appealing strategy for 
diagnosing infection or deconvoluting infection histories. Finally, the 
individuality of the baseline repertoire of each subject suggests that 
the personalization of vaccine delivery and therapeutic intervention 
may produce substantial benefits in the treatment and prevention of 
infectious diseases.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments 
were not randomized and investigators were not blinded to allocation during 
experiments and outcome assessment.
Leukapheresis samples. Full leukopaks (three blood volumes) were obtained from 
ten human subjects (Hemacare). Samples were collected at Hemacare’s Southern 
California donor centre. Sample collection was performed under a protocol 
approved by the Institutional Research Boards of Scripps Research and Hemacare. 
Informed consent was obtained from each subject. All subjects were healthy, HIV-
negative adults between the ages of 18 and 30 with no reported acute illness in the 
14 days before leukapheresis. The subject pool was gender-balanced and evenly 
divided between African-American and Caucasian individuals (ethnicity was 
self-reported; Extended Data Table 1). Immediately upon receipt of the leukopak, 
peripheral blood mononuclear cells were purified by gradient centrifugation and 
cryo-preserved.
Amplification strategy and primer bias. We elected to use RNA as the template 
for antibody variable gene amplification, as this focuses our analysis on productive 
heavy-chain rearrangements and permits the use of amplification primers that 
anneal to the CH1 region (owing to the presence of an intron between the JH 
gene and CH region, the use of CH1 primers is not feasible when amplifying from 
DNA). The decision to use RNA has some inherent downsides, however—primarily 
the likelihood of overrepresentation of transcriptionally active B cells (namely, 
memory B cells and plasmablasts). It should be noted that the use of molecular 
barcodes, which enable identification and collapsing of reads that originate from 
the same RNA molecule, will not correct this problem. To reduce the influence of 
multiplexed primer sets on the resulting composition of antibody genes that are 
amplified, we designed an amplification strategy that limits the use of multiplexed 
primers that anneal to the V-gene region in an attempt to reduce primer bias during 
amplification. Following cDNA synthesis, second-strand synthesis was performed 
using multiplexed V-gene primers that encode an overhang that comprises a por-
tion of the Illumina adapters required for next-generation sequencing. V-gene 
primers were then enzymatically removed before subsequent amplification of the 
antibody genes using the conserved overhang as the primer annealing site. Thus, 
the multiplexed V-gene primers were only used for a single round of amplification.
Antibody gene amplification. For each subject, total RNA was separately iso-
lated from 6 aliquots of approximately 5 × 108 cryo-preserved peripheral blood 
mononuclear cells (RNeasy Maxi, Qiagen). For each RNA aliquot, antibody genes 
were amplified in triplicate (18 total samples per subject), with each of the tech-
nical replicates processed independently and starting with a separate aliquot of 
the RNA sample. To minimize the likelihood of crosscontamination between 
subjects, reverse transcription and PCR reactions for each subject were pro-
cessed in isolation, such that samples from two different subjects were never in 
proximity during amplification reaction preparation. All primers20 are listed in 
Extended Data Table 2. To increase the sequencer-perceived nucleotide diversity 
during each sequencing cycle, ‘offsets’ were added to the reverse-transcription and 
second-strand synthesis primers. Three sets of these primers were synthesized, 
with each set containing 2, 4 or 6 random nucleotides at the offset position (see 
Extended Data Table 2). These offsets stagger the conserved constant and frame-
work regions and result in much higher diversity during each sequencing cycle, and 
minimize the required PhiX spike. cDNA synthesis was performed on 11 μl of RNA 
using 10 pmol of each primer in a 20-μl total reaction (SuperScript III, Thermo 
Fisher Scientific), using the manufacturer’s protocol and the following thermal 
cycling program: 55 °C for 60 min, 70 °C for 15 min. Residual primers and dNTPs 
were degraded enzymatically (ExoSAP-IT, Thermo Fisher Scientific), according 
to the manufacturer’s protocol. The entire enzyme-treated cDNA synthesis prod-
uct was used in a 100-μl second-strand synthesis reaction using 10 pmol of each 
primer (HotStarTaq Plus, Qiagen) using the following thermal cycling protocol: 
95 °C for 5 min, 55 °C for 30 s, 72 °C for 10 min. Residual primers and dNTPs 
were again degraded enzymatically (ExoSAP-IT) and dsDNA was purified using 
0.8 volumes of SPRI beads (AmpureXP, Beckman Coulter Genomics) and eluted 
in 50 μl of water. Antibody genes were amplified using 40 μl of eluted dsDNA and 
10 pmol of each primer in a 100-μl total reaction volume (HotStarTaq Plus), using 
the following thermal cycling program: 95 °C for 5 min; 25 cycles of: 95 °C for 30 s, 
58 °C for 30 s, 72 °C for 2 min; 72 °C for 10 min. DNA was purified from the 
PCR reaction product using 0.8 volumes of SPRI beads (AmpureXP) and eluted 
in 50 μl of water. Subsequently, 10 μl of the eluted PCR product was used in a 
final indexing PCR (HotStarTaq Plus) using 10 pmol of each primer in 100-μl 
total reaction volume and using the following thermal cycling program: 95 °C for 
5 min; 10 cycles of: 95 °C for 30 s, 58 °C for 30 s, 72 °C for 2 min; 72 °C for 10 min. 
PCR products were purified with 0.7 volumes of SPRI beads (SPRIselect, Beckman 
Coulter Genomics) and the entire set of samples from a single subject was eluted 
in a single 120-μl volume of water.
Sequencing. SPRI-purified sequencing libraries were initially quantified using 
fluorometry (Qubit, Thermo Fisher Scientific) before size determination using 
a Bioanalyzer (Agilent 2100). Libraries were requantified using qPCR (KAPA 
Biosystems) before sequencing on an Illumina HiSeq 2500 using 2 × 250-bp 
Rapid Run chemistry.
Raw sequence processing. Raw paired FASTQ files were quality checked with 
FASTQC (www.bioinformatics.babraham.ac.uk/projects/fastqc/). Because the 
5′ end of each paired read encodes the unique molecular identifier (UMI), reads 
were quality trimmed only at the 3′ end using Sickle (www.github.com/najoshi/
sickle), using a window size of 0.1 times the length of the read, minimum average 
window quality score of 20, and a minimum read length after trimming of 50 nucle-
otides. Because UMIs are located on the ‘outside’ of the gene-specific primers used 
for amplification (see Extended Data Fig. 1b), primer trimming was delayed until 
after UMI processing. Processed reads were quality checked again using FASTQC, 
and paired reads were merged with PANDAseq using the default (simple_bayesian) 
merging algorithm21.
Molecular barcodes. Although sequencing libraries were constructed to encode 
molecular barcodes on both ends of the amplicon, we observed low-level PCR 
recombination22 that produced ‘barcode swapping’, causing the frequency of these 
amplification artefacts to be amplified. In essence, a partial amplification product—
composed of a CDRH3 and an incomplete VH gene—was able to prime a different 
antibody sequence and continue amplification, producing a hybrid VH gene. This 
hybrid amplicon encodes the 3′ molecular barcode from the primary antibody 
recombination and the 5′ molecular barcode from the second. The barcode swap-
ping creates a unique barcode pair, forcing the hybrid sequence to be binned and 
processed separately. To minimize the effects of such barcode swapping, we binned 
sequences using only the 3′ molecular barcode. Because the likelihood of UMI 
collisions was relatively high given the sequencing depth, the CDRH3 nucleotide 
sequences of each UMI bin containing more than one sequence were clustered 
at high identity (90%) and a consensus sequence was computed for each cluster. 
For UMI bins containing only a single sequence, the lone sequence was used as 
the representative for the respective UMI bin. Because our sequencing depth was 
approximately equal to the number of input cells (~3 × 108 sequencing reads 
from ~3 × 108 input B cells), the majority of UMI bins contained only a single 
sequencing read. As such, the UMIs were not used primarily for error correction, 
but as a means for correcting differential representation arising from stochastic 
or primer-driven amplification biases. Mutation frequencies in the IgM and IgG 
sequence populations (Extended Data Fig. 3) provide empirical evidence of a 
low amplification and sequencing error rate that corroborates sequencer-derived 
quality metrics.
Germline gene assignment and annotation. Adapters and V-gene amplification 
primers (used for second-strand synthesis) were removed using cutadapt23. cDNA 
synthesis primers, which anneal to the CH1 region, were not removed because this 
region is needed to determine the isotype. Sequences were annotated with abstar4 
and two output formats were generated: a comprehensive JSON-formatted output, 
which was imported into a MongoDB database; and a minimal CSV-formatted 
output, which is tabular and suitable for direct parsing or conversion to Parquet 
for querying on a Spark cluster.
Antibody clonotypes. Antibody clonotypes, defined as a collection of sequences 
that use the same V and J germline segments and encode an identical CDRH3 
amino acid sequence, were used throughout this study to reduce the influence of 
sequencing or amplification error. Although collapsing the V or J regions to just 
the germline assignment removes the possibility of double-counting sequences 
that differ only by error(s) in the V- or J-gene region, it does not eliminate the 
effect of error in the CDRH3 sequence. To gauge the effect of sequencing and 
amplification error in CDRH3 on clonotype diversity, we collapsed sequences into 
clonotypes allowing either no mismatches in the CDRH3 amino acid sequence or 
a single mismatch in the CDRH3 sequence. The total number of one-mismatch 
clonotypes was lower than the number of zero-mismatch clonotypes by only 5.9% 
on average (3.4–9.5%), which is as expected when collapsing a sequence population 
that contains expanded antibody lineages (Extended Data Fig. 5), and indicates that 
CDRH3 sequencing errors do not contribute meaningfully to clonotype diversity. 
Thus, only zero-mismatch clonotypes were used for all further experiments using 
clonotypes.
Estimation of light-chain diversity relative to heavy chain diversity. Estimation 
of light-chain diversity is in some ways more complex than estimating heavy-
chain diversity, owing to the relatively high frequency of coincidentally identical 
recombinations14. Rather than sequencing unpaired light chains and attempting 
to discern independent rearrangements from distinct copies of RNA derived 
from the same recombination event, we leveraged a novel dataset of paired anti-
body heavy and light chains to estimate the diversity of light chains relative to 
the diversity of heavy chains14. For each of the three subjects for which paired 
heavy- and light-chain sequencing data were available, we estimated the total 
richness using Chao 2 and Recon estimators. Each subject was sequenced in 
duplicate, and separated estimates were computed for each sequencing replicate. 
Because the sequencing depth was far lower in the paired dataset than in the 
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large-scale experiment described here, we extrapolated the richness estimates 
so that the paired richness estimates were more comparable with the large-scale 
estimates. Although such an extrapolation may introduce a non-trivial amount 
of variance into the richness estimates, we believe that this provides the most 
accurate estimate of relative light-chain diversity that is currently available. 
Diversity estimates and the associated extrapolations can be found in Extended 
Data Fig. 7. The highest ratio of heavy-chain to light-chain richness (indicating 
the lowest diversity of light chains relative to heavy chains) was observed with the 
Chao 2 estimator (3.8 × 103). Conservatively, we rounded this ratio up to 
the nearest order of magnitude (104) when computing the total paired repertoire 
diversity estimates.
Generating synthetic repertoires based on a probabilistic model of V(D)J 
recombination. We created a total of 3 billion synthetic antibody sequences using 
IGoR16 with one of three different approaches. First, we created 10 sequence 
batches—each containing 108 synthetic antibody sequences—using IGoR’s 
default recombination model, which was inferred from unproductive antibody 
rearrangements. The reason for using unproductive rearrangements for inferring 
IGoR’s default recombination model is that productive rearrangements are sub-
ject to a variety of selection processes during B cell maturation (negative selec-
tion of autoreactive clones, requirement for productive pairing with a light chain, 
and so on), whereas unproductive rearrangements are subject to none of these 
selection processes. Thus, a model inferred from unproductive rearrangements 
incorporates only information about the V(D)J recombination process. Second, we 
inferred subject-specific recombination models using 5 × 105 randomly selected 
IgM sequences that were entirely unmutated in the V-gene region. Ten synthetic 
sequence batches, each containing 108 sequences, were then generated—one 
batch per subject. Finally, we inferred a combined-subject recombination model 
using a pool of 5 × 105 umutated IgM sequences from all 10 subjects (5 × 104 
sequences per subject, randomly selected from the sequences used to generate 
the subject-specific models). As with IGoR’s default model, 10 separate batches 
of 108 synthetic sequences were generated with the combined-subject model. All 
synthetic sequences were processed in the same manner as the observed antibody 
sequences, except that the adapter trimming and UMI-based correction steps were 
not performed. Kullback–Leibler divergence between models or model ‘events’ 
was computed with the pygor package, which is distributed with IGoR (Extended 
Data Fig. 8).
Morisita–Horn similarity. Antibody sequences from each subject were reduced 
to only the V-gene, J-gene and CDRH3 length (and were randomly subsam-
pled with replacement at sample sizes ranging from 101 to 107). The frequency 
of each V-gene, J-gene and CDRH3 length was computed, and the frequency 
distributions from two donors were used to compute the Morisita–Horn 
similarity index:
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in which xi is the number of times the V-gene, J-gene and CDRH3 length i is rep-
resented in one sample of size X; and yi is the number of times the V-gene, J-gene 
and CDRH3 length i is represented in a second sample of size Y.
Rarefaction. For each subject, all unique clonotypes from each of the biological 
replicates were pooled. For varying sample sizes (ranging from 0.1 to 1.0 as a frac-
tion of the total number of pooled clonotypes), samples were randomly drawn 
without replacement and the number of unique clonotypes in the sample was com-
puted. For each sample size, a total of 10 independent samplings were performed, 
with the exception of the 1.0 fraction, which was only sampled once (as samplings 
of the entire dataset will always produce the same result).
Classification of repertoires by subject. Repertoires were classified using a one-
versus-rest support-vector-machine classifier. Classifier training and evaluation 
were performed in Python using the scikit-learn framework. It is important to note 
that this classification was performed using only ten subjects and expanding the 
subject pool to thousands or millions of individuals, while maintaining classifier 
accuracy, would likely require much larger training datasets and/or the inclusion 
of additional sequence features to supplement the V-gene, J-gene and CDRH3 
length. Additionally, because the repertoire of each subject will be altered by new 
immunological encounters and ongoing turnover in the naive B cell population, 
it is possible that these high-level sequence feature frequencies will change sub-
stantially over time.
Statistical calculations. Statistical calculations were performed in Python using 
SciPy (www.scipy.org) or Seaborn (seaborn.pydata.org).
Reporting summary. Further information on research design is available in 
the Nature Research Reporting Summary linked to this paper.
Code availability. Code used to produce the figures is available at www.github.
com/briney/grp_paper. All code used for classification can be found at www.github.
com/briney/grp_paper. Abstar is available at www.github.com/briney/abstar. Code 
for molecular barcode processing is available at www.github.com/briney/abtools.
Data availability
Sequence data that support the findings in this study are available at the NCBI 
Sequencing Read Archive (www.ncbi.nlm.nih.gov/sra) under BioProject num-
ber PRJNA406949. Raw and processed datasets are available at www.github.com/
briney/grp_paper.
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Extended Data Fig. 1 | Nearly full-length antibody gene amplification 
from biological and technical replicate samples. a, Schematic of 
biological and technical replicate samples. Biological replicates (columns) 
are derived from distinct cell aliquots, so identical clonotypes or sequences 
found in multiple biological replicates must arise from different cells. 
Technical replicates (rows) were amplified using discrete RNA aliquots 
from a single-cell aliquot. b, Strategy for nearly full-length antibody heavy 
chains. Black arrows indicate primers. Primers in the cDNA synthesis step 
anneal to the heavy-chain constant region (CH) and add the first unique 
molecular identifier (UMI) and the Illumina read 1 primer annealing site. 
Primers in the second-strand synthesis step anneal to the framework  
1 region of the variable gene and add a second UMI and the Illumina read 
2 primer annealing site.
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Extended Data Fig. 2 | V and J frequency correlations of technical 
and biological replicates. For each subject, the frequency of V and 
J combinations was compared for technical replicates (left panels) or 
biological replicates (right panels). The coefficient of determination (r2) is 
shown for each plot.
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Extended Data Fig. 3 | Nucleotide mutation frequencies. a, The 
distribution of nucleotide mutations in sequences that encode IgM are 
shown. On the right, the number of unmutated sequences containing no 
mutations in the variable-gene segment is also plotted. b, The distribution 
of nucleotide mutations in sequences that encode IgG are shown. On the 
right, the mean mutation frequency for the IgG population of each subject 
is shown. Each line represents a single subject. For legibility, the legend is 
split between the two plots. Although only five subjects are shown in the 
legend of each plot, data from all ten subjects is present in each plot.
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Extended Data Fig. 4 | Cross-subject repertoire similarity. Pairwise 
Morisita–Horn similarity comparisons between each subject and all 
other subjects. Similarity was computed using the frequency of V-gene, 
J-gene and CDRH3 length combinations. Each line represents the mean 
of 20 independent repertoire samplings (with replacement). The shading 
surrounding the mean line indicates the 95% confidence interval.
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Extended Data Fig. 5 | Collapsing sequences into clonotypes. a, To 
demonstrate the effect of collapsing an expanded clonal lineage into 
clonotypes, we selected a previously reported lineage of Zika-specific 
monoclonal antibodies isolated from the plasmablast population of 
an acutely infected patient24. Of 119 sequences, 89 were unique at the 
nucleotide level. b, Sequences encoding the same V gene, J gene and an 
identical CDRH3 amino acid sequence were collapsed into clonotypes, 
and the sequence phylogeny was coloured by clonotype. A total of 119 
sequences were collapsed into 18 clonotypes. c, Sequences were collapsed 
into clonotypes, allowing a single mismatch in the CDRH3 amino acid 
sequence, and the sequence phylogeny was coloured by clonotype. A total 
of 119 sequences were collapsed into 10 clonotypes. d, The clonotype 
fraction (number of clonotypes divided by the total number of filtered 
sequences), when collapsing clonotypes while allowing zero or one 
mismatch in the CDRH3 amino acid sequence for each subject in this 
study. e, Number of total clonotypes recovered when allowing zero or one 
mismatch in the CDRH3 amino acid sequence for each subject in this 
study.
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Extended Data Fig. 6 | Capture–recapture frequency. a, Recapture 
frequency for each subject. Lines represent the mean of 10 random 
samplings (without replacement) for all subsample fractions except 
compete sampling (1.0). b, Mean recapture frequency for each subsample 
fraction.
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Extended Data Fig. 7 | Relative light-chain diversity estimation. Using 
previously reported datasets of paired heavy and light antibody chains, 
clonotype diversity was estimated for heavy and light chains using both 
Chao 2 and Recon estimators. Estimates are shown in filled or unfilled 
points. Lines indicate the least-squares polynomial best fit (degree = 2) 
and is extrapolated to include both the lowest (1.17 × 108) and highest 
(9.06 × 108) number of UMI-corrected sequences from the 10 sequenced 
subjects.
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Extended Data Fig. 8 | Variance between inferred V(D)J recombination 
models. a, Frequency of clonotype sharing between observed human 
subjects (black), synthetic datasets generated with IGoR’s default 
recombination model (red), synthetic datasets generated with subject-
specific recombination models (blue) or synthetic datasets generated 
with a combined-subject recombination model (purple). b, Combined 
Kullback–Leibler divergence (KL divergence) between pairs of subject-
specific models (blue), between subject-specific models and IGoR’s default 
model (red), or between subject-specific models and the combined-subject 
model (purple). c, Combined KL divergence between pairs of subject-
specific models, separated by event type.
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Extended data table 1 | demographic information and sequencing statistics per subject
All ethnicities are self-reported. AA, African-American; C, Caucasian.
© 2019 Springer Nature Limited. All rights reserved.
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Extended data table 2 | Primers used for antibody gene amplification
Regions in parentheses indicate offset positions. Random offset nucleotides are added in multiples of two. RT, reverse transcription; X, position of Illumina TruSeq indices.
© 2019 Springer Nature Limited. All rights reserved.
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